Pharmaceutical Chemicals Powder CAS 72558-82-8 Ceftazidime

• Powder: Yes
• Customized: Customized
• Certification: GMP, ISO 9001, USP, BP
• Suitable for: Adult
• State: Solid
• Purity: >98%
• Model NO.: ceftazidime
• Name: Ceftazidime
• Mf: C22h22n6o7s2
• CAS: 72558-82-8
• Whsapp: 86 152 029 61574
• Transport Package: Drum
• Specification: 99%
• Trademark: HS
• Origin: China
• HS Code: 2904201000
• Production Capacity: 100000

Product Description

 

 

Product Name	Ceftazidime
CAS No.	72558-82-8
Molecular Formula	C22H22N6O7S2
Molecular Weight	546.58
Specification	99%
Appearance	Light yello  Powder

 

Product Name: Ceftazidime (contains ca. 10% Na2CO3)
CAS No.  72558-82-8
Molecular Formula: C22H22N6O7S2
Molecular Weight: 546.58
Specification: 99%
Appearance:White Powder
Assay:99%min
Shelf Life:24 months when properly stored
Storage:Keep in a cool, dry, dark location
Ceftazidime (Ceftazidime) is the third generation cephalosporin. The pneumococcus, Streptococcus and Staphylococcus aureus and gram positive bacteria was weaker than cefazolin; resistant to Staphylococcus aureus and Enterococcus methicillin ineffective against gram negative bacteria; just as powerful, such as good on Escherichia coli, Klebsiella pneumoniae, proteus, Sha Lei bacteria, bacillus, influenza Pseudomonas aeruginosa, Neisseria gonorrhoeae, meningococcal has antibacterial activity; gram positive anaerobic aerobic bark on Motoki Shinami, but the resistance of Bacteroides fragilis.
It is also used for the lower respiratory tract, skin and soft tissue, bone and joint, thoracic cavity, abdominal cavity, urogenital system and central infection caused by sensitive strains of Gram-negative bacteria. It is also used for septicemia.

Function
1.For pneumonia and lower respiratory tract infection caused by Gram-negative bacilli, intraperitoneal and biliary tract infections, complex urinary tract infections and severe skin and soft tissue infections, etc. It is especially suitable for immunodeficiency caused by multi-drug resistant Gram bacilli, nosocomial infection and infection of central nervous system caused by Gram-negative bacilli or Pseudomonas aeruginosa.
2. It is clinically used for general severe infections caused by sensitive bacteria (such as sepsis, meningitis, bacteremia), respiratory tract infections (such as pneumonia, bronchitis), ear, nose and throat infections, skin and soft tissue infections, urinary tract infections, gastrointestinal, biliary and abdominal infections, bone and joint infections, etc.

 

Batch No.	HF171121	Quantity	8.5kgs
Mfg. Date	Nov. 21, 2017	Package	As required
Rep. Date	Nov. 25, 2017	Exp. Date	Nov. 20, 2019
Items	Standards		Results
Appearance	White or off-white solid powder		Complies
Identification	By IR		Complies
	By HPLC		Complies
Solubility	Soluble in DMF, sparingly soluble in THF, slightly soluble in methanol and acetonitrile, very sightly soluble in ethanol and dichloromethane, insoluble in water		Complies
Polymorphic Form	Polymorphic form 1		Complies
Melting Point	211ºC~216ºC		212.8ºC~214.9ºC
Water Content	≤ 0.50%		0.10%
Heavy Metals	≤ 20ppm		Complies
Residue on Ignition	≤ 0.20%		0.09%
Related Substance	Any single impurity: ≤0.10%		0.06%
	Total Impurities: ≤1.00%		0.16%
Assay                  (on the anhydrous basis)	98.0%~102.0%		99.94%
Particle Size	D90: ≤100µm		Complies
Reference Standard	In-house Standard
Conclusion	The product complied to In-house standard.
Storage	Preserve in tight,light-resistant containers in a cool place